217 related articles for article (PubMed ID: 19542426)
1. Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells.
Stewart TJ; Liewehr DJ; Steinberg SM; Greeneltch KM; Abrams SI
J Immunol; 2009 Jul; 183(1):117-28. PubMed ID: 19542426
[TBL] [Abstract][Full Text] [Related]
2. Interferon regulatory factor-8 modulates the development of tumour-induced CD11b+Gr-1+ myeloid cells.
Stewart TJ; Greeneltch KM; Reid JE; Liewehr DJ; Steinberg SM; Liu K; Abrams SI
J Cell Mol Med; 2009 Sep; 13(9B):3939-50. PubMed ID: 20196788
[TBL] [Abstract][Full Text] [Related]
3. Gr-1+CD11b+ cells are responsible for tumor promoting effect of TGF-β in breast cancer progression.
Li Z; Pang Y; Gara SK; Achyut BR; Heger C; Goldsmith PK; Lonning S; Yang L
Int J Cancer; 2012 Dec; 131(11):2584-95. PubMed ID: 22487809
[TBL] [Abstract][Full Text] [Related]
4. Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells.
Narita Y; Wakita D; Ohkur T; Chamoto K; Nishimura T
Biomed Res; 2009 Feb; 30(1):7-15. PubMed ID: 19265258
[TBL] [Abstract][Full Text] [Related]
5. miR-130a and miR-145 reprogram Gr-1
Ishii H; Vodnala SK; Achyut BR; So JY; Hollander MC; Greten TF; Lal A; Yang L
Nat Commun; 2018 Jul; 9(1):2611. PubMed ID: 29973593
[TBL] [Abstract][Full Text] [Related]
6. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.
Turnquist HR; Zhao Z; Rosborough BR; Liu Q; Castellaneta A; Isse K; Wang Z; Lang M; Stolz DB; Zheng XX; Demetris AJ; Liew FY; Wood KJ; Thomson AW
J Immunol; 2011 Nov; 187(9):4598-610. PubMed ID: 21949025
[TBL] [Abstract][Full Text] [Related]
7. Premetastatic soil and prevention of breast cancer brain metastasis.
Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H
Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625
[TBL] [Abstract][Full Text] [Related]
8. Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro.
Han EC; Lee J; Ryu SW; Choi C
Biochem Biophys Res Commun; 2014 Jan; 443(4):1218-25. PubMed ID: 24388986
[TBL] [Abstract][Full Text] [Related]
9. IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.
Medina-Echeverz J; Haile LA; Zhao F; Gamrekelashvili J; Ma C; Métais JY; Dunbar CE; Kapoor V; Manns MP; Korangy F; Greten TF
Eur J Immunol; 2014 Aug; 44(8):2457-67. PubMed ID: 24810636
[TBL] [Abstract][Full Text] [Related]
10. Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung.
Yan HH; Pickup M; Pang Y; Gorska AE; Li Z; Chytil A; Geng Y; Gray JW; Moses HL; Yang L
Cancer Res; 2010 Aug; 70(15):6139-49. PubMed ID: 20631080
[TBL] [Abstract][Full Text] [Related]
11. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
[TBL] [Abstract][Full Text] [Related]
12. Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions.
Pande K; Ueda R; Machemer T; Sathe M; Tsai V; Brin E; Delano MJ; Van Rooijen N; McClanahan TK; Talmadge JE; Moldawer LL; Phillips JH; LaFace DM
Mol Ther; 2009 Mar; 17(3):508-15. PubMed ID: 19127252
[TBL] [Abstract][Full Text] [Related]
13. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.
Yang R; Cai Z; Zhang Y; Yutzy WH; Roby KF; Roden RB
Cancer Res; 2006 Jul; 66(13):6807-15. PubMed ID: 16818658
[TBL] [Abstract][Full Text] [Related]
14. Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor.
Connolly MK; Mallen-St Clair J; Bedrosian AS; Malhotra A; Vera V; Ibrahim J; Henning J; Pachter HL; Bar-Sagi D; Frey AB; Miller G
J Leukoc Biol; 2010 Apr; 87(4):713-25. PubMed ID: 20042467
[TBL] [Abstract][Full Text] [Related]
15. Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
Spallanzani RG; Dalotto-Moreno T; Raffo Iraolagoitia XL; Ziblat A; Domaica CI; Avila DE; Rossi LE; Fuertes MB; Battistone MA; Rabinovich GA; Salatino M; Zwirner NW
Cancer Immunol Immunother; 2013 Dec; 62(12):1781-95. PubMed ID: 24114144
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.
Kapanadze T; Medina-Echeverz J; Gamrekelashvili J; Weiss JM; Wiltrout RH; Kapoor V; Hawk N; Terabe M; Berzofsky JA; Manns MP; Wang E; Marincola FM; Korangy F; Greten TF
Eur J Immunol; 2015 Apr; 45(4):1148-58. PubMed ID: 25616156
[TBL] [Abstract][Full Text] [Related]
17. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE
Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629
[TBL] [Abstract][Full Text] [Related]
18. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
[TBL] [Abstract][Full Text] [Related]
19. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis.
Yi H; Guo C; Yu X; Zuo D; Wang XY
J Immunol; 2012 Nov; 189(9):4295-304. PubMed ID: 23034169
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice.
Abe F; Dafferner AJ; Donkor M; Westphal SN; Scholar EM; Solheim JC; Singh RK; Hoke TA; Talmadge JE
Cancer Immunol Immunother; 2010 Jan; 59(1):47-62. PubMed ID: 19449184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
